These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23131373)

  • 1. Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
    Patil NJ; Nagaratna R; Garner C; Raghuram NV; Crisan R
    Complement Ther Med; 2012 Dec; 20(6):424-30. PubMed ID: 23131373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study.
    McClurg D; Ashe RG; Marshall K; Lowe-Strong AS
    Neurourol Urodyn; 2006; 25(4):337-48. PubMed ID: 16637070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Effect of pranayama and meditation as an add-on therapy in rehabilitation of patients with Guillain-Barré syndrome--a randomized control pilot study".
    Sendhilkumar R; Gupta A; Nagarathna R; Taly AB
    Disabil Rehabil; 2013 Jan; 35(1):57-62. PubMed ID: 22621705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study.
    Chobe S; Bhargav H; Raghuram N; Garner C
    J Complement Integr Med; 2016 Sep; 13(3):301-309. PubMed ID: 27337744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction.
    Guillotreau J; Castel-Lacanal E; Roumiguié M; Bordier B; Doumerc N; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    Neurourol Urodyn; 2011 Nov; 30(8):1503-6. PubMed ID: 21674595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosis.
    Raviv G; Shefi S; Nizani D; Achiron A
    Complement Ther Clin Pract; 2009 May; 15(2):72-5. PubMed ID: 19341983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of neurogenic bladder patient whose pre-void bladder capacity was correlated with the post-void residual volume].
    Kuroda S; Noguchi K; Takahashi T; Nakamura M; Kawai M; Murai T; Murai M
    Hinyokika Kiyo; 2014 Jun; 60(6):287-90. PubMed ID: 25001645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yoga Training Has Positive Effects on Postural Balance and Its Influence on Activities of Daily Living in People with Multiple Sclerosis: A Pilot Study.
    de Oliveira G; Tavares Mda C; de Faria Oliveira JD; Rodrigues MR; Santaella DF
    Explore (NY); 2016; 12(5):325-32. PubMed ID: 27426024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research and clinical experience in the treatment of the neurogenic bladder by electronic implant and prostheses.
    Alexander S
    Paraplegia; 1968 Nov; 6(3):183-93. PubMed ID: 5752112
    [No Abstract]   [Full Text] [Related]  

  • 11. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Help for patients with multiple sclerosis: current diagnostic and treatment possibilities in neurogenic disorders of bladder emptying].
    Zwergel U; Wullich B; Jost WH; Zwergel T
    Dtsch Med Wochenschr; 1998 May; 123(22):707-12. PubMed ID: 9645188
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experience.
    Legrand G; Rouprêt M; Comperat E; Even-Schneider A; Denys P; Chartier-Kastler E
    Urology; 2011 Oct; 78(4):937-41. PubMed ID: 21820707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial.
    Gobbi C; Digesu GA; Khullar V; El Neil S; Caccia G; Zecca C
    Mult Scler; 2011 Dec; 17(12):1514-9. PubMed ID: 21757534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
    Cameron AP; Rodriguez GM; Gursky A; He C; Clemens JQ; Stoffel JT
    J Urol; 2015 Nov; 194(5):1336-41. PubMed ID: 25956470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
    Stievano LP; Olival GS; Silva RA; Toller VB; Carabetta EG; da Cunha ET; Moreira Rde J; Eloi M; Tilbery CP
    Arq Neuropsiquiatr; 2015 Jan; 73(1):46-51. PubMed ID: 25608127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overactive bladder in multiple sclerosis.
    Fingerman JS; Finkelstein LH
    J Am Osteopath Assoc; 2000 Mar; 100(3 Suppl):S9-12. PubMed ID: 10763312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.